Typicality: | 0.509 |
Saliency: | 0.228 |
for individuals with a bleeding disorder | 8 | transitive-object |
to reduce the risk | 7 | purpose |
with booster doses | 2 | other |
vaccine → be given by → deep subcutaneous injection | 8 |
vaccine → be administered by → subcutaneous route | 5 |
vaccine → be given in → subcutaneous tissue | 3 |
negative | neutral | positive |
0.191 | 0.749 | 0.060 |
Raw frequency | 16 |
Normalized frequency | 0.228 |
Modifier score | 1.000 |
Perplexity | 26.637 |